BNP PARIBAS ARBITRAGE, SA

Q3 2020 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
9/30/2020
Date filed
10/30/2020
Form type
13F-HR
Num holdings
10,017
Total value ($000)
$69,900,298
Net value change ($000)
+13,211,225 (23.3%)
New positions
26
Sold out positions
114
Turnover %
0.9%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
QQQ 2,189,022 123.3%
AMZN 528,352 75.6%
MSFT 378,322 37.5%
AAPL 368,753 21.6%
IWM 358,735 45.1%
BABA 356,692 55.3%
XLV 307,567 292.6%
TSLA 252,514 77.3%
MET 194,782 1534.9%
AMT 183,528 213.1%
Top Reduces (Value $000, Stocks/ETFs)
XBI -347,210 -39.8%
XLF -284,537 -67.7%
MTCH -202,610 -100.0%
V -165,445 -57.0%
ABBV -153,454 -39.6%
XLU -139,192 -30.1%
SPY -130,363 -6.3%
DIA -126,367 -57.7%
TIFFANY & CO -123,860 -94.9%
ACWI -122,269 -37.4%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 22,198,724 (31.8% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 BNP PARIBAS SECURITIES CORP
2 BNP PARIBAS